Emerging Biotech
The expanded deal builds on a previous agreement signed in June 2021, under which Innovent is granted to deploy Synaffix's ADC technologies on a targe...
December 07, 2023 | News
The majority of NK cells administered on day 14 are CD56brightCD16-NK cells, which primarily enhance immune function but show reduced expr...
December 05, 2023 | News
ISM5411 is an oral, PHD-specific inhibitor that facilitates the treatment of IBD by inducing the expression of gut barrier protective genes. ISM5411 is ...
December 05, 2023 | News
The Chairman of the Supreme Council of Health, Lt. General Dr. Shaikh Mohammed bin Abdulla Al Khalifa, highlighted the ongoing efforts within the Nati...
November 30, 2023 | News
Building upon an ongoing collaboration that was initiated in December 2022 to utilize artificial intelligence (AI) and automation to develop targ...
November 22, 2023 | News
Before, the publicly listed company at the group level had already secured approximately US$ 60 million in convertible bond financing, which will...
November 21, 2023 | News
Metabolon, Inc., the global leader in providing metabolomics solutions advancing a wide variety of life science research, and Trajan Scientific and Medical...
November 21, 2023 | News
Clostridioides difficile infection (CDI) is a common hospital-acquired infection worldwide. Recurrence and mortality rates have been reported to be up...
November 17, 2023 | News
Results from a first-in-human clinical trial showed that SCG101 demonstrated promising antiviral and antitumor activities in patients with advanced HBV-rel...
November 14, 2023 | News
The R&D Center will focus on advancing molecular diagnostic technologies and novel therapeutic platforms. Situated at the heart of the burgeoning biote...
November 13, 2023 | News
Cromatic, a full-stack digital platform for outsourced life sciences research, announced it has closed $5.3 million in funding. LifeX Ventures ...
November 10, 2023 | News
Safety Review Committee evaluated dose level 1 safety data of PMC-403 and approved advancing to the higher dose treatment. The starting dose (0.7m...
November 10, 2023 | News
DiscGenics, Inc., a privately held, late-stage clinical, biopharmaceutical company focused on developing regenerative cell-based therapies that alleviate p...
November 10, 2023 | News
This investment will support Genome Insight’s pursuit of bringing whole-genome based precision diagnostics to routine clinical care. Earlier this yea...
November 03, 2023 | News
Most Read
Bio Jobs
News